Chordate Medical Holding publ AB

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

57.24%

Rev. gr., 5y

-10.60%

Revenues

665k

-31.92%

Net income

-27m

L-6.62%

CFO

-24m

L-10.47%

Profile

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

URL

https://www.chordate.com/

IPO date

Mar 08, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title SEK in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title SEK in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	665 -31.92%	976 799.66%	109 -87.70%
Cost of revenue	(1,324)	1,654	21,124
Unusual Expense (Income)
NOPBT	1,989	(678)	(21,015)
NOPBT Margin	299.17%
Operating Taxes			(81)
Tax Rate
NOPAT	1,989	(678)	(20,934)
Net income	(27,254) -6.62%	(29,187) 4.45%	(27,943) 28.38%
Dividends
Dividend yield
Proceeds from repurchase of equity	21,362	33,200	65
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities	1		1
Net debt	(2,530)	(8,546)	(3,758)
Cash flow
Cash from operating activities	(24,408)	(27,263)	(24,979)
CAPEX	(1,102)	(378)	(389)
Cash from investing activities	(2,880)	(1,158)	(389)
Cash from financing activities	21,362	33,200	65
FCF	1,576	(796)	(21,064)
Balance
Cash	2,530	8,455	3,676
Long term investments		91	82
Excess cash	2,496	8,497	3,752
Stockholders' equity	(16,169)	345,604	(248,072)
Invested Capital	25,364	6,589	259,145
ROIC	12.45%
ROCE	21.63%
EV
Common stock shares outstanding	1,025	224,513	415
Price
Market cap
EV
EBITDA	4,208	559	(18,562)
EV/EBITDA
Interest		7	81
Interest/NOPBT